Sector: MedicalCOMBINATORX (NASDAQ: CRXX)
Headlines
- CombinatoRx Oncology Programs to Be Highlighted at ASH 2009
Nov 24, 2009 07:30 AM | CRXX
- BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen
Nov 20, 2009 03:08 PM | CRL, CRXX, DNDN, POZN
- FDA Extends NDA Review for Exalgo(TM) Extended-Release Tablets
Nov 20, 2009 07:30 AM | CRXX
- BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
Nov 16, 2009 11:56 AM | ALKS, CRL, CRXX, CYTX, HGSI, HHS
- CombinatoRx'S Synavive (CRx-102) Maintains Efficacy Throughout 12 Month Phase 2 Knee OA Extension Trial
Oct 21, 2009 07:30 AM | CRXX
- CombinatoRx Abstract Accepted for Oral Presentation at ACR 2009
Oct 08, 2009 07:30 AM | CRXX
- Levi & Korsinsky LLP Investigates Possible Breach of Fiduciary Duty by Board of CombinatoRx, Inc. - CRXX
Sep 30, 2009 02:25 PM | CRXX
- Swine Flu Stocks Moving Markets at Mid Week
Sep 24, 2009 01:16 AM | CRXX, CVM, XOMA
- CombinatoRx Stock Trading Halted Today; FDA Advisory Committees Meet to Discuss Exalgo
Sep 23, 2009 07:05 AM | CRXX
- BioMed News Bytes: CRXX, STSI, ACTC.PK
Sep 22, 2009 05:20 PM | CRXX
- FDA Extends NDA Review for Exalgo Extended-Release Tablets
Nov 20, 2009 07:54 AM | CRXX
- Neuromed Receives FDA Feedback on New Drug Application for Exalgo Extended-Release Tablets
Nov 16, 2009 07:52 AM | CRXX
- CombinatoRx Reports Financial Results for the Third Quarter 2009
Nov 03, 2009 07:52 AM | CRXX
- CombinatoRx-Derived Combination Drug Candidate, Prednisporin, Acquired By Sanofi-Aventis Through Proposed Acquisition of Fovea Pharmaceuticals
Oct 05, 2009 07:53 AM | CRXX
- CombinatoRx Reports Financial Results for the Second Quarter 2009
Aug 10, 2009 07:50 AM | CRXX
- CombinatoRx to Webcast Conference Call Discussing Second Quarter 2009 Financial Results
Jul 31, 2009 08:01 AM | CRXX
- CombinatoRx Publishes Research Demonstrating Improved Selectivity Through Synergistic Combinations
Jul 06, 2009 08:05 AM | CRXX
- CombinatoRx and Neuromed Sign Merger Agreement
Jul 01, 2009 07:51 AM | CRXX, SEPR
- CombinatoRx Presents Full Data on Synavive Phase 2 Knee OA Trial at EULAR 2009
Jun 12, 2009 07:32 AM | CRXX
- CombinatoRx Granted Extension to Regain NASDAQ Compliance
Jun 10, 2009 10:09 AM | CRXX
- Form 3 Renz Justin A For: Jul 01 (10K)
Jul 01, 2009 12:54 PM
- Form 4 Cole Jason For: Jan 26 (10K)
Jan 28, 2009 04:28 PM
- Form 4 Forrester Robert For: Jan 26 (10K)
Jan 28, 2009 04:28 PM
- Form 4 Borisy Alexis For: Jan 26 (10K)
Jan 28, 2009 04:28 PM
- Form 4 COMBINATORX, INC For: Dec 03 Filed by: BIOTECHNOLOGY VALUE FUND L P (10K)
Dec 05, 2008 05:16 PM
- Form 4 COMBINATORX, INC For: Dec 01 Filed by: BIOTECHNOLOGY VALUE FUND L P (10K)
Dec 03, 2008 05:26 PM
- Form 4 COMBINATORX, INC For: Nov 21 Filed by: BIOTECHNOLOGY VALUE FUND L P (10K)
Nov 25, 2008 04:56 PM
- Form 4 COMBINATORX, INC For: Nov 07 Filed by: BVF INC/IL (10K)
Nov 12, 2008 05:37 PM
- Form 4 COMBINATORX, INC For: Oct 15 Filed by: BVF INVESTMENTS LLC (10K)
Oct 17, 2008 05:53 PM
- Form 4 COMBINATORX, INC For: Oct 10 Filed by: BVF INC/IL (10K)
Oct 15, 2008 06:46 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CRXX
|
Compare to S&P
|
| YTD |
72.58 %
|
42.83 %
|
| 4 Weeks |
-19.55 %
|
-20.42 %
|
| 12 Weeks |
-17.69 %
|
-22.40 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 15.79 %
|
|
EPS Growth in Last Year: 64.44 %
|
|
Sales Growth in Last Quarter: -17.36 %
|
|
Sales Growth in Last Quarter: -21.23 %
|
|
